logo-loader

MMJ PhytoTech positioned to become 'the Berkshire Hathaway of cannabis’

Last updated: 12:14 04 Oct 2018 BST, First published: 22:14 03 Oct 2018 BST

MMJ Phyto Tech Ltd (ASX:MMJ) chief executive officer Jason Conroy speaks to Proactive Investors about the cannabis investment company’s global portfolio of assets and strategic approach to the cannabis sector.

“We invest up to about $5 million per investment across the cannabis value chain and across different stages of investment, either early-stage venture capital, seed capital, through to growth funding and pre-IPO funding.

“I’ve been with the company for about 6 months now and my vision for the company is really just to turn it into the Berkshire Hathaway of cannabis.

“Our model is built around backing very experienced management teams who understand the space but also understand old-fashioned things like operating cash-flow and how to calculate risk-adjusted returns and manage their business in an appropriate way.”

MMJ Group focuses on strategic vision to be leading cannabis investment company

MMJ Group Holdings Ltd (ASX: MMJ) non-executive director Mike Curtis updates Proactive Investors about its strategic partnership with MMJ operating company Embark Ventures (EBV). The two companies have combined to create the highest quality investments, earnings and share price return for...

on 17/7/19